Search

Positive clinical data, increases in federal funding and the first regulatory approval of a manufactured stem cell product mean momentum is building in the US. With the re-election of President Obama, this is likely to continue

The EU must continue to support human embryonic stem cell research to maintain its lead in regenerative medicine. The upcoming Irish Presidency needs to recognise the importance of this research and resist calls for a ban on funding in Horizon 2020

As part of the Science|Business Special Report on stem cell research, experts give their opinion on the much debated topic

Spin-out Liquid Light builds on research results that languished in the lab for 10 years – reverse combustion process produces methanol from CO2. Next step: industrial scale production.

A fresh approach to studying entrepreneurialism – which combines policy with individual drive – provides the insights needed to identify and address bottlenecks says Erkko Autio

Is a frozen “rollover” budget for 2013 and beyond now likely? MEPs debate the EU budget at a Science|Business event, as negotiations between Parliament and Council collapse

Interview with Professor David Zilberman, professor of agricultural and resource economics at the University of California, Berkeley and principal investigator at the UC Berkeley Energy Biosciences Institute

Cash-strapped member states want to reduce the EU’s overall budget, putting the proposed increase in R&D spending under threat. That will make it more difficult to revive Europe’s jaded economy, Teresa Riera Madurell MEP tells Science|Business

Research bodies and industry groups have joined Europe’s top scientists in calls to deliver on the proposal to increase the R&D budget to €80 billion